Moroni Marco, Ghezzi Silvia, Baroli Paolo, Heltai Silvia, De Battista Davide, Pensieroso Simone, Cavarelli Mariangela, Dispinseri Stefania, Vanni Irene, Pastori Claudia, Zerbi Pietro, Tosoni Antonella, Vicenzi Elisa, Nebuloni Manuela, Wong Kim, Zhao Hong, McHugh Sarah, Poli Guido, Lopalco Lucia, Scarlatti Gabriella, Biassoni Roberto, Mullins James I, Malnati Mauro S, Alfano Massimo
Infectious Disease Unit, Busto Arsizio Public Hospital, P.le Solaro n. 3, Busto Arsizio, 21052, Varese, Italy.
Viral Pathogens and Biosafety Unit, Division of Immunology, Transplantation and Infectious Disease, San Raffaele Scientific Institute, Milan, Italy.
J Transl Med. 2014 Dec 5;12:335. doi: 10.1186/s12967-014-0335-6.
Understanding the mechanisms by which some individuals are able to naturally control HIV-1 infection is an important goal of AIDS research. We here describe the case of an HIV-1(+) woman, CASE1, who has spontaneously controlled her viremia for the last 14 of her 20 years of infection.
CASE1 has been clinically monitored since 1993. Detailed immunological, virological and histological analyses were performed on samples obtained between 2009 and 2011.
As for other Elite Controllers, CASE1 is characterized by low to undetectable levels of plasma HIV-1 RNA, peripheral blood mononuclear cell (PBMC) associated HIV-1 DNA and reduced in vitro susceptibility of target cells to HIV-1 infection. Furthermore, a slow rate of virus evolution was demonstrated in spite the lack of assumption of any antiretroviral agent. CASE1 failed to transmit HIV-1 to either her sexual male partner or to her child born by vaginal delivery. Normal values and ratios of T and B cells were observed, along with normal histology of the intestinal mucosa. Attempts to isolate HIV-1 from her PBMC and gut-derived cells were unsuccessful, despite expression of normal cell surface levels of CD4, CCRC5 and CXCR4. CASE1 did not produce detectable anti-HIV neutralizing antibodies in her serum or genital mucosal fluid although she displayed potent T cell responses against HIV-1 Gag and Nef. CASE1 also possessed multiple genetic polymorphisms, including HLA alleles (B14, B57, C06 and C08.02) and HLA-C single nucleotide polymorphisms (SNPs, rs9264942 C/C and rs67384697 del/del), that have been previously individually associated with spontaneous control of plasma viremia, maintenance of high CD4(+) T cell counts and delayed disease progression.
CASE1 has controlled her HIV-1 viremia below the limit of detection in the absence of antiretroviral therapy for more than 14 years and has not shown any sign of immunologic deterioration or disease progression. Co-expression of multiple protective HLA alleles, HLA-C SNPs and strong T cell responses against HIV-1 proteins are the most likely explanation of this very benign case of spontaneous control of HIV-1 disease progression.
了解某些个体能够自然控制HIV-1感染的机制是艾滋病研究的一个重要目标。我们在此描述一名HIV-1阳性女性CASE1的病例,她在感染的20年中的最后14年里自发控制了病毒血症。
自1993年以来对CASE1进行了临床监测。对2009年至2011年期间获取的样本进行了详细的免疫学、病毒学和组织学分析。
与其他精英控制者一样,CASE1的特征是血浆HIV-1 RNA水平低至无法检测、外周血单个核细胞(PBMC)相关的HIV-1 DNA水平低,以及靶细胞对HIV-1感染的体外易感性降低。此外,尽管未使用任何抗逆转录病毒药物,但仍显示出病毒进化速度缓慢。CASE1未能将HIV-1传播给她的男性性伴侣或通过阴道分娩出生的孩子。观察到T细胞和B细胞的正常值及比例,以及肠黏膜的正常组织学。尽管她的细胞表面CD4、CCR5和CXCR4水平正常,但从她的PBMC和肠道来源细胞中分离HIV-1均未成功。CASE1在其血清或生殖黏膜液中未产生可检测到的抗HIV中和抗体,尽管她对HIV-1 Gag和Nef表现出有效的T细胞反应。CASE1还具有多种基因多态性,包括HLA等位基因(B14、B57、C06和C08.02)以及HLA-C单核苷酸多态性(SNPs,rs9264942 C/C和rs67384697 del/del),这些多态性先前已分别与血浆病毒血症的自发控制、高CD4+ T细胞计数的维持以及疾病进展延迟相关。
CASE1在未接受抗逆转录病毒治疗的情况下将其HIV-1病毒血症控制在检测限以下超过14年,且未显示出任何免疫恶化或疾病进展的迹象。多种保护性HLA等位基因、HLA-C SNPs的共同表达以及对HIV-1蛋白的强烈T细胞反应最有可能解释了这种HIV-1疾病进展自发控制的非常良性的病例。